For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() Leidos Holdings Inc.LDOS US · Industrials · USD Current price$124.32as of Nov 20, 2026 Summary
Analyst consensusStrong Buy 2Buy 4Hold 1115 analysts 3-year price (USD)Factor profileMulti-factor score 64 / 100 Market data
Business descriptionLeidos Holdings Inc. (LDOS) provides technology services and systems integration to defence, intelligence, civil, and health markets — spanning critical mission software, digital modernization and cyber, energy infrastructure, space and maritime systems, and managed health services. The company operates under the "NorthStar 2030" strategy built on those five pillars, deliberately shifting its mix toward technology production and systems integration rather than pure advisory work. Competitive moat
Recent developments
Investment risks / red flags
Financials
Classification
|
Last updated: Oct 22, 2026
Current price: $124.32 · Nov 20, 2026· USD
CFRA Ratinghold12-Mo Target: $145.00
TBI Multi Score64
Loading graph…
Factor Profile (Spider Chart)
TBI ModelPrice Chart (TradingView)
Symbol: LDOSBusiness description
Leidos Holdings Inc. (LDOS) provides technology services and systems integration to defence, intelligence, civil, and health markets — spanning critical mission software, digital modernization and cyber, energy infrastructure, space and maritime systems, and managed health services. The company operates under the "NorthStar 2030" strategy built on those five pillars, deliberately shifting its mix toward technology production and systems integration rather than pure advisory work.
Competitive moat
- Defence inflection with visibility: The Defense segment posted a 2.2x book-to-bill ratio and is on a path to double-digit growth, with a $12B pipeline of Defense Tech opportunities over the next 12 months.
- Cyber scale via Kudu: The Kudu acquisition helped grow the cyber pipeline 21% to $24B, positioning LDOS in the highest-priority national-security budget lines.
- Energy resilience exposure: The Entrust acquisition expanded the energy order pipeline to $10B, a market increasingly funded by grid-security and resilience mandates.
- Procurement-workforce gap: Congressional concern over a weakened federal acquisition workforce favours large, trusted integrators that can execute complex programmes, a structural advantage over smaller advisory competitors.
Recent developments
- Q2 2026 (08/04/2026): Strong revenue beat and record cash flow, partly offset by margin pressure and the Health-segment drag.
- VA MDE suspension: The VA suspended all incentive payments for the medical disability exam programme for the rest of 2026, a direct hit to a high-margin profit contributor, with no visibility yet on the upcoming MDE recompete.
- NorthStar 2030 execution: Early wins cited in unmanned maritime systems, grid-resilience projects, and national-defence cyber.
Investment risks / red flags
- Health-segment margin risk: The MDE incentive suspension and the pending recompete introduce material uncertainty into a key profit pool.
- Continuing resolution exposure: An extended CR stretching into 2026 delays awards and revenue conversion.
- Execution and integration: Security-products execution challenges and integration risk from recent acquisitions (Kudu, Entrust, cyber assets).
- Competitive and renewal risk: Higher competitive losses or failure to renew large contracts would hit the backlog.
Market Data
Source: mkts.io · Nov 20, 2026, 18:01 UTC
Key Metrics
P/E (TTM)11.11
P/E (Fwd)10.52
Dividend1.38%
Beta0.54
52W High$205.00
52W Low$98.86
Analyst Consensus
2
4
11
Strong Buy2Buy4Hold1115 analysts
Consensus Target$153.73
+23.7% upside
Calendar Events
Next EarningsNov 3, 2026
Ex-DividendDec 15, 2026
Dividend DateDec 31, 2026
Financials
Revenue$17.80B
Rev Growth3.60%
Earnings Growth16.30%
Gross Margin17.63%
Op Margin11.84%
Profit Margin7.97%
EBITDA$2.41B
ROA9.08%
ROE28.27%
Rev/Share$142.36
Total Cash$630.00M
Total Debt$6.56B
D/E Ratio125.63
Free Cash Flow$1.04B
Op Cash Flow$2.11B
Current Ratio1.60
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 2.68 | $4.49B |
| +1q | 2.89 | $4.52B |
| 0y | 12.68 | $18.08B |
| +1y | 11.82 | $18.53B |
Earnings
Quarterly EPS
4Q2025
Est: 2.612.76Beat
1Q2026
Est: 2.913.13Beat
2Q2026
Est: 2.913.26Beat
3Q2026
Est: 3.033.62Beat
Annual
2022
Rev $14.40BEarn $685.00M
2023
Rev $15.44BEarn $199.00M
2024
Rev $16.66BEarn $1.25B
2025
Rev $17.17BEarn $1.45B
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Nov 10, 2026 | Citigroup | main | Buy |
| Oct 8, 2026 | JP Morgan | down | Neutral |
| Oct 7, 2026 | Citigroup | main | Buy |
| Oct 6, 2026 | Jefferies | main | Hold |
| Oct 6, 2026 | TD Cowen | main | Hold |
| Sep 18, 2026 | B of A Securities | main | Neutral |
